LastPass enabled for Apple Watch
Apple Watch owners just need to launch LastPass on their iPhone to enable LastPass for Apple Watch from the app’s “Settings” menu. The update is available with version 3.1.9 on the App Store. LastPass for Apple Watch is included in the LastPass Premium upgrade for $12 per year.
In the future LastPass is hoping to utilize Apple Watch as a biometric two-factor option for securing a LastPass account.
Encap upgrades enable smartphone biometrics
Encap Security announced support for Samsung’s fingerprint scanner as part the 3.0 version release of its Smarter Authentication platform. The update includes a range of new features that enable financial institutions to use smart device capabilities to deliver personalized and contextual access to digital services across any channel.
The platform can now scale to support any smart device and extend to incorporate any new authentication capability made possible by device manufacturers now or in the future. This includes the latest biometrics such as Samsung’s fingerprint scanner as well as legacy technologies such as SMS one-time-passwords for feature phones.
The new features in the release include:
- Device agnostic – supports authentication for any device including feature phones
- Extensibility – ability to add existing and new device-based authentication technologies
- Context data – the provision of device and user intelligence to determine the optimal authentication method, flag risks, and alter security level in proportion
- Geolocation – high accuracy location as a parameter in the context data
- Offline device mode – allows the smart device to be used as an authentication factor even when no data connection is available
- App Defender – defends against malware, even on jailbroken or compromised devices, through deep, multi-layered, malware and tampering protection
Exostar providing identity services to Meditab users
Meditab Inc., the developer of Intelligent Medical Software (IMS), has chosen Exostar’s ProviderPass to extend IMS to deliver electronic prescription for controlled substances functionality. The solution meets requirements issued by the Drug Enforcement Administration while offering a consistent user experience for providers who have come to rely on IMS.
To help prevent controlled substances from falling into the wrong hands, the DEA mandated the following actions for any provider who is e-prescribing schedule II, III, IV, and V controlled substances:
- Complete a stringent identity proofing process
- Perform a two-factor authentication process to verify the identity
- Use a digital signature while submitting a prescription
Meditab’s IMS ClientConnect portal enables providers to initiate a remote identity-proofing event, conducted in partnership with Exostar via Experian or a live web cam video. The IMS ClientConnect portal also lets health care providers place shipping orders for One Time Password hardware tokens that serve as the credentials for second factor authentication.
Exostar’s ProviderPass enables IMS to meet DEA requirements by activating the OTP hardware token credential for providers following the successful completion of the identity proofing event and authenticating the token each time it is presented for access to EPCS functionality within the e-prescription module. Each provider receives a unique hardware token, reducing the risk for unauthorized access while ensuring compliance and accountability.